GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MagForce AG (OTCPK:MGFRF) » Definitions » 3-Year EBITDA Growth Rate

MagForce AG (MagForce AG) 3-Year EBITDA Growth Rate : 0.00% (As of Dec. 2021)


View and export this data going back to 2013. Start your Free Trial

What is MagForce AG 3-Year EBITDA Growth Rate?

MagForce AG's EBITDA per Share for the six months ended in Dec. 2021 was $-0.14.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of MagForce AG's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, MagForce AG's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MagForce AG's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MagForce AG's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where MagForce AG's 3-Year EBITDA Growth Rate falls into.



MagForce AG 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


MagForce AG  (OTCPK:MGFRF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


MagForce AG 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of MagForce AG's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


MagForce AG (MagForce AG) Business Description

Traded in Other Exchanges
N/A
Address
Max-Planck-Stresse 3, Berlin, DEU, 12489
MagForce AG is a medical engineering company. The company operates in the area of nanotechnology-based cancer treatment. Its medical devices include NanoTherm therapy used for local treatment of solid tumors, NanoTherm a liquid that reacts to the presence of a magnetic field, NanoPlan uses the bioheat transfer equation, and NanoActivator used for tumors in all areas of the body.

MagForce AG (MagForce AG) Headlines